Shanmuga Hospital Ltd

Shanmuga Hospital Ltd has announced a Board of Directors meeting scheduled for November 12, 2026. The primary agenda items include the consideration and approval of the unaudited financial results for the quarter and half-year ended September 30, 2026. Additionally, the board will discuss the declaration of a first interim dividend, if any, for the Financial Year 2026-27. The company has also informed that the trading window for its securities will remain closed until 48 hours after the declaration of these financial results.

Shanmuga Hospital Ltd has officially launched its "Shanmuga 360" mobile application for commercial use on October 20, 2026. This digital healthcare platform aims to provide patients with convenient access to various services, including appointment booking, lab tests, ambulance services, and medicine purchases. The launch signifies a key step in the company's digital healthcare strategy, focusing on enhancing patient convenience and accessibility. The company plans to further enhance the application's features and services in a phased manner.

Shanmuga Hospital Ltd has announced the closure of its trading window from October 01, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half-year ending September 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. All designated persons, their immediate relatives, and other insiders are prohibited from trading in the company's equity shares during this period. The date of the board meeting to approve these financial results will be communicated later.

Shanmuga Hospital Ltd announced that its members have approved an increase in the company's authorized share capital from ₹14 crore to ₹25 crore. This significant increase, comprising 1.4 crore equity shares of ₹10 each to 2.5 crore equity shares of ₹10 each, was approved at the company's 6th Annual General Meeting (AGM) held on September 18, 2026. The approval is subject to the final clearance from the Registrar of Companies (ROC). This move will lead to a subsequent alteration in the company's Memorandum of Association (MOA), specifically Clause V, reflecting the expanded share capital.

Shanmuga Hospital Ltd. announced that its members, at the 6th Annual General Meeting held on September 18, 2026, approved special resolutions to amend the Memorandum of Association (MoA) and alter the Articles of Association (AoA). The MoA amendment expands the company's main object clause to include providing administrative, operational, management, technical, academic, training, consultancy, and allied support services to various medical and educational institutions. It also adds the business of designing, developing, and dealing in computer software, mobile, and web applications. The AoA alteration involves inserting new definitions, substituting existing share capital provisions, and adding new clauses for variation of shareholder rights and further issue of share capital. The MoA amendment is subject to approval from the Registrar of Companies.

Shanmuga Hospital Ltd. announced that its shareholders, at the Sixth Annual General Meeting (AGM) held on September 18, 2026, approved the appointment of CS S Anuradha, a Practising Company Secretary, as the Secretarial Auditor. The appointment is for a term of five consecutive financial years, commencing from FY 2026-27 and extending up to FY 2030-31. This decision was made effective from April 1, 2026, and is in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Shanmuga Hospital Ltd has filed its 6th Annual Report for the financial year 2025-26, in compliance with SEBI regulations. The report details the hospital's commitment to providing safe, compassionate, and high-quality healthcare. It includes a corporate overview, director's report highlighting performance and strategic initiatives, financial statements, auditor's report, and annexures. The company also announced its 6th Annual General Meeting (AGM) will be held on September 18, 2026, via Video Conference. The full annual report is available on the company's website.

Shanmuga Hospital Ltd has announced its 6th Annual General Meeting (AGM) will be held on Friday, September 18, 2026, at 02:30 PM IST. The meeting will be conducted via Video Conference or Other Audio Visual Means. Key agenda items include the adoption of audited financial statements for the fiscal year ended March 31, 2026, the re-appointment of two directors retiring by rotation (Mrs. Panneerselvam Jayalakshmi and Mr. Karuppiah Saravanan), and a special resolution to increase the authorized share capital from ₹14 crore to ₹25 crore, along with a consequential amendment to the Memorandum of Association. Another special resolution concerns amendments to the main object clause of the Memorandum of Association. The full notice is available on the company's website.

Shanmuga Hospital Ltd announced a board meeting where several key decisions were made, subject to shareholder approval. The company plans to increase its authorized share capital from ₹14 crore to ₹25 crore. Additionally, the board approved the formulation of the "Shanmuga Hospital Limited Employee Stock Option Plan 2026" (SHL ESOP-2026) and appointed Finshore Management Service Ltd. as the Merchant Banker for this plan. The company also approved alterations to its Memorandum of Association (MOA) to include new object clauses for future business expansion and diversification, and to reflect the increased authorized share capital. Other approvals included the unaudited financial results for the quarter ended June 30, 2026, and entering into a power purchase agreement with LNGS Private Limited. The 6th Annual General Meeting is scheduled for September 18, 2026.

Shanmuga Hospital Ltd announced a significant increase in its authorized share capital from ₹14 crore to ₹25 crore, subject to shareholder approval at the upcoming AGM. The board also approved the un-audited financial results for the quarter ended June 30, 2026, and a power purchase agreement with LNGS Private Limited. Additionally, the company is introducing the 'Shanmuga Hospital Limited Employee Stock Option Plan 2026' (SHL ESOP-2026) and has appointed Finshore Management Service Ltd. as the merchant banker for this plan. The Memorandum of Association will be amended to reflect these changes, including the addition of new main object clauses to facilitate future business diversification.